We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Wageningen University and DNASTAR Extend Lasergene Site License Agreement
News

Wageningen University and DNASTAR Extend Lasergene Site License Agreement

Wageningen University and DNASTAR Extend Lasergene Site License Agreement
News

Wageningen University and DNASTAR Extend Lasergene Site License Agreement

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Wageningen University and DNASTAR Extend Lasergene Site License Agreement"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

DNASTAR and Wageningen University and Research centre in Wageningen, the Netherlands announced the signing of a broad site license agreement for the use of Lasergene® sequence analysis software developed by DNASTAR.

Under the terms of the site license, all researchers in the Department of Agrotechnology and Food Sciences will have unlimited use of the software for their sequence analysis projects. The site license will include the latest version of Lasergene, v8.1, which provides users with automated virtual MultiSite Gateway cloning capabilities, along with numerous other new features.

Lasergene, a comprehensive sequence analysis software program sold in more than 65 countries worldwide, provides users with tools to perform a wide range of DNA assembly, visualization and analysis operations on data generated by the conventional Sanger sequencing method as well as Next Generation platforms available from Roche 454, Illumina, ABI SOLiD and Helicos. It can also be used in a wide range of protein analysis applications. Additional Lasergene information and Free Trial versions of the software are available.

Bob Steinhauser, DNASTAR’s Director of Marketing stated, “Wageningen UR and DNASTAR have been working together for many years. This is the second department-wide site license for the use of our software at the University. We are extremely pleased that as the activities at the University have grown, DNASTAR has been able to grow with them. Lasergene’s novel features, broad applications base and constant updating with new Features, makes it an excellent sequence analysis platform choice to address present and future genomic research needs.”
Advertisement